Back to Aberdeen Group plc Aberdeen Group plc

DYNDYN
9 quarters

Position history for Aberdeen Group plcAberdeen Group plc's holdings in DYNE THERAPEUTICS INC

Aberdeen Group plc holds 1.5M shares of DYN (DYNE THERAPEUTICS INC), worth $34.2M as of 2026-Q2. The position was increased (+7.6% shares). DYN represents 0.0% of Aberdeen Group plc's portfolio.

Current Value

$34.2M

Current Shares

1.5M

Total Value Change

+$33.6M

Total Shares Change

+1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.5M
+7.6%
$34.2M0.0%$22.21
31
2026-Q1
Increased
1.4M
+29.1%
$25.9M0.0%$14.60
36
2025-Q4
Increased
1.1M
+99.0%
$21.7M0.0%$19.20
46
2025-Q3
Increased
556,733
+15.0%
$7M0.0%$12.37
31
2025-Q2
Increased
483,963
+53.8%
$4.6M0.0%$9.57
38
2025-Q1
Increased
314,586
+1119.2%
$3.3M0.0%$11.45
43
2024-Q4
New
25,803
-
$607,9190.0%$23.65
34
2024-Q3
Exited
0
-100.0%
$00.0%$33.83
0
2024-Q2
New
17,869
-
$630,5970.0%$35.29
34

Other major holders of DYN: BlackRock, Inc., Janus Henderson Group Ltd., BlackRock Finance, Inc., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used